Bowel Screening Products

Alpha Laboratories has a wealth of expertise and experience through its long history of supplying the National Bowel Screening Programmes with gFOBT and FIT tests.

We have been involved with the National Bowel Cancer Screening programme since 1998, as the key supplier of hema-screen™ (FOBT - faecal occult blood tests). Moving to more advanced, sensitive and specific methods the screening programmes are now adopting faecal immunochemical testing (FIT) and Alpha Laboratories has been instrumental in helping to roll this out.

The use of quantitative FIT in the assessment of the symptomatic is changing too, as more publications have demonstrated its use as a “rule-out” test has benefits to clinicians, laboratories and patients. It can be used to triage patients presenting with abdominal symptoms as a step in the patient pathway to help manage colonoscopy resources more efficiently.

Quantitative Faecal Immunochemical Testing Automated System - HM-JACKarc

Faecal Immunochemical Test (FIT) for Bowel Cancer Detection - recommended by NICE DG30

High quality measurement of faecal haemoglobin for both asymptomatic and symptomatic assessment for bowel cancer and other colorectal diseases.
Quantitative Faecal Immunochemical Testing Automated System - HM-CODIAM
Designed to meet the evolving demands of colorectal cancer screening and symptomatic testing services, the HM-CODIAM represents the next generation of Faecal Immunochemical Test (FIT) analysis from Canon Medical Diagnostics Corporation.
Qualitative Faecal Immunochemical Testing
DIAQUICK FOB qualitative faecal immunochemical tests Easy dip-stick sampler and lateral flow test cassette presentation that qualitatively detects haemoglobin in faeces samples.